Canadian Rheumatology Association Position Statement on Medical Cannabis Use in Rheumatic Disease

With the legalization of cannabis on October 17, 2018, Canadians may increasingly turn to their physicians for guidance regarding medical cannabis use, which has already entered mainstream medicine.

In the absence of studies examining the effects of medical cannabis in patients with rheumatic diseases, a position statement has been developed and published in the to help rheumatologists to offer pragmatic advice to their patient in a caring and empathetic way to ensure harm reduction. It was published online in The Journal of Rheumatology.

A copy of the statement can be found here.